Ubl Remedies Private Limited - Company Profile

It is a business services private limited company based in Bangalore South, Karnataka, India, established in 2023.
2023 Bangalore South, Karnataka, India Active
Last Updated:
Access Report
About Ubl Remedies Private Limited

Ubl Remedies Private Limited, a active private limited company, was established on 03 July 2023 in Bangalore South, Karnataka, India. it holds CIN: U46497KA2023PTC175447. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Mohini Prakash (Director), Jyoti Srivastava (Managing Director), Amit Jaiswal (Director). Past directors included Chetna Bharti Ranjan, Vivek Kumar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Ashutosh Kumar,Flat, No.A-319,Midtown Opulent, Bangalore South, Karnataka, 560066.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497KA2023PTC175447

  • Registration Number

    175447

  • Incorporation Date

    03 July 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Ubl Remedies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ubl Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ubl Remedies Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohini Prakash Director 03 Jul 2023 Current
Jyoti Srivastava Managing Director 03 Jul 2023 Current
Amit Jaiswal Director 20 Jun 2025 Current
Poonam Rani Srivastava Director 30 May 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Jan 2025 Past
Pramod Abcsdd Director 02 Jan 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ubl Remedies.

Enhance accessibility to Ubl Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ubl Remedies revenue growth over time
Ubl Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ubl Remedies?

Unlock access to Ubl Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ubl Remedies?

Unlock and access historical data on people associated with Ubl Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ubl Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ubl Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ubl Remedies
Recent Activity within the Organization
  • Annual General Meeting

    Ubl Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Amit Jaiswal was appointed as a Director was appointed as a Director on 20 Jun 2025 & has been associated with this company since 8 months 10 days . was documented.

  • Director Appointment

    Progress on Poonam Rani Srivastava was appointed as a Director was appointed as a Director on 30 May 2025 & has been associated with this company since 9 months 1 day . was documented.

  • Balance Sheet

    Progress on Ubl Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.

  • Director Appointment

    Progress on Mohini Prakash was appointed as a Director was appointed as a Director on 03 Jul 2023 & has been associated with this company since 2 years 7 months . was documented.

  • Director Appointment

    Progress on Jyoti Srivastava was appointed as a Managing Director was appointed as a Managing Director on 03 Jul 2023 & has been associated with this company since 2 years 7 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ubl Remedies Private Limited?

The CIN of Ubl Remedies Private Limited is U46497KA2023PTC175447.

Where is Ubl Remedies Private Limited headquartered?

Ubl Remedies Private Limited is headquartered at C/O Ashutosh Kumar,Flat, No.A-319,Midtown Opulent, Bangalore South, Karnataka, 560066.

When was Ubl Remedies Private Limited incorporated?

Ubl Remedies Private Limited was incorporated on 03 July 2023.

Who are the current directors of Ubl Remedies Private Limited?

The current directors of Ubl Remedies Private Limited are

Is Ubl Remedies Private Limited a listed company?

Ubl Remedies Private Limited is unlisted.

What is the capital structure of Ubl Remedies Private Limited?

The authorized capital of Ubl Remedies Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available